10 Best Up And Coming Stocks To Watch Right Now


NEW YORK — With Russia backing away from its war games in Ukraine — at least for now — an old Wall Street worry is back in focus: jobs.

On Friday, the government issues its February employment report. How many jobs were created, and what the new unemployment rate is, have implications for Federal Reserve policy. It also provides an update on the health of the economy and could influence investor confidence, says Kristina Hooper, U.S. investment strategist at Allianz Global Investors.


WILSHIRE 5000: It’s above 20,000 now

TRACK STOCKS : Get real-time quotes with our free Portfolio Tracker

Wall Street is forecasting 150,000 new jobs in February, up from a disappointing 113,000 in January, PNC says. Economists expect the jobless rate to remain unchanged at 6.6%.

10 Best Up And Coming Stocks To Watch Right Now: Biota Pharmaceuticals Inc (BOTA)

Biota Pharmaceuticals, Inc., formerly Nabi Biopharmaceuticals, incorporated on March 14, 1969, is an anti-infective drug development company, with key expertise in respiratory diseases, particularly influenza. Biota developed the neuraminidase inhibitor, zanamivir, subsequently marketed by GlaxoSmithKline as Relenza. The Company’s researches include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections. In addition, Biota and Daiichi Sankyo co-own a range of second generation influenza anti-virals, of which the lead product lnavir, is approved for marketing in Japan.


The Company’s products include Zanamivir, Inavi, Phoslyra, BioStar OIA FLU and BioStar OIA FLU A/B. Zanamivir is a neuraminidase inhibitor for the treatment and prophylaxis of influenza marketed as Relenza by GlaxoSmithKline. Inavi (laninamivir) is a neuraminidase inhibitor marketed by Daiichi Sankyo in Japan. Phoslyr a is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). BioStar OIA FLU and BioStar OIA FLU A/B are influenza diagnostic tests, which are marketed by Inverness Medical as part of their BioStar product range.


Relenza is delivered directly to the primary site of infection on the lungs, using a Disk Inhaler device. Relenza is approved in over 50 countries for the treatment of influenza, including in the United States, the European Union, Japan and Australia. Relenza is also approved for use as a preventative (prophylactic) treatment against influenza. Inavir is approved for sale in Japan for the treatment of influenza in adults and children. Daiichi Sankyo has applied to sell Inavir in Japan for the prevention of influenza.

PhosLo and Phoslyra are different dose forms of calcium acetate; a phosphate binder approved in multiple countries for the control of hyperphosphatemia (high serum phosphate) in patients with end stage renal disease (ESRD). PhosLo and Pho! slyra were sold to Fresnius Medical Care. Biota, together with its Japanese based partner, Daiichi Sankyo, have developed an inhaled antiviral compounds for influenza, called long acting inhaled neuraminidase inhibitors (LANI). Biota’s human rhinovirus (HRV) drug for the prevention and treatment of the causes of the common cold, BTA798, has completed Phase I, Phase IIa and Phase IIb clinical trials.


Advisors’ Opinion:

  • [By gurujx]

    Biota Pharmaceuticals Inc (BOTA) Reached the 3-year Low of $2.42

    The prices of Biota Pharmaceuticals Inc (BOTA) shares have declined to close to the 3-year low of $2.42, which is 93.3% off the 3-year high of $34.92.

10 Best Up And Coming Stocks To Watch Right Now: Cott Corp (COT)

Cott Corporation (Cott), incorporated on December 31, 2006, is a producers of beverages on behalf of retailers, brand owners and distributors. The Company’s product lines include carbonated soft drinks (CSDs), 100% shelf stable juice and juice-based products, clear, still and sparkling flavored waters, energy products, sports products, new age beverages, and ready-to-drink teas, as well as alcoholic beverages for brand owners. The Company operates in five segments: North America (which includes the United States operating segment and Canada operating segment), the United Kingdom (which includes its United Kingdom reporting unit and its Continental European reporting unit), Mexico, Royal Crown International (RCI) and All Other. The Company markets or supplies over 500 retailer, licensed and Company-owned brands in its four core geographic segments. In March of 2012, its U.K. reporting segment acquired a beverage and wholesale business based in Scotland.


Advisors’ Opinion:

  • [By kcpl]

    It wasn’t a good quarter for Cott Corporation (COT) as the company had trouble with its volumes. Cott Corporation engages in the production and distribution of retailer brand beverages in North America and globally. It offers carbonated soft drinks, flavored waters, energy-related drinks, juice, juice-based products, bottled water and ready-to-drink teas. It primarily serves grocery, mass-merchandise, drugstore, wholesale and convenience store chains.

  • [By Rick Munarriz]

    It’s been a year of brand-widening initiatives for SodaStream, and not just because it cranked out its first Super Bowl ad back in February.


    In February it teamed up with Ocean Spray to co-develop cranberry juice blends exclusively for the SodaStream system. This follows deals last year with Crystal Light, Kool-Aid, and V8 for non-conventional carbonated beverages. My 2012 wish for SodaStream to strike a deal with Monster Beverage (NASDAQ: MNST  ) to make a bigger splash in the energy-drinks market hasn’t materialized, but a deal with EBOOST did happen earlier this year. The initial natural energy drink flavors of orange and acai pomegranate will hit the market as SodaStream syrups during the latter half of this year, packing an all-natural energy boost and vitamins in every serving. EBOOST doesn’t have the same allure as Monster or Red Bull, but the move was still a strong one since there’s a real value proposition for home-crafted energy drinks. If SodaStream is successful, the big boys will be on notice. In March, SodaStream, which is based in Israel, teamed up with private-label bottler Cott (NYSE: COT  ) to produce SodaStream’s existing flavors at its facility in Georgia, making it easier to get SodaStream products into the country with the world’s largest soda consumption per capita.


    The next chapter in what has been a successful year will naturally write itself on Wednesday. There is plenty to prove, even after SodaStream proves quarter after quarter that it’s not just a company behind a faddish novelty.

  • [By Dan Caplinger]

    But SodaStream is continuing to pull out all stops in order to improve its results. SodaStream’s recent partnership with Samsung to incorporate carbonation technology into high-end refrigerators could help drive growth for consumers who don’t want to deal with a separate appliance in their kitchens. Moreover, SodaStream’s deal in March with bottler Cott (NYSE: COT  ) to produce soda syrup within the U.S. should help it boost its efficiency in getting flavors to domestic customers.

  • [By Nicole Seghetti]

    Private-label pressures
    Regardless, private labels are becoming a bigger problem for companies such as Kraft and, to a lesser extent, Mondelez. According to an industry profile compiled by First Research, these brands typically cost 20% to 40% less than name-brand products. Couple that with the fact that more consumers are ditching big brands, and we can easily see why ConAgra (NYSE: CAG  ) , Cott (NYSE: COT  ) , and others are continually strengthening their private-label positions.

10 Best Up And Coming Stocks To Watch Right Now: Coronado Biosciences Inc (CNDO)


Coronado Biosciences, Inc., incorporated on June 28, 2006, is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn’s disease (Crohn’s), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML). In January 2011, the Company acquired the OvaMed GmbH License.


TSO

TSO is the microscopic eggs of a parasitic helminth, or worm, that is found in pigs. In September 2011, the Company filed an Investigational New Drug Application (IND) with t he United States Food and Drug Administration (FDA) and it initiated a single dose, dose escalation study in patients with Crohn’s in February 2012. The Phase 1 clinical trial was a multi-center, sequential dose-escalation, double-blind, placebo-controlled study, the primary objective of which was to evaluate the safety and tolerability of TSO. The trial enrolled 36 patients with Crohn’s ranging in age from 20 to 54 with an equal distribution of male and female patients in three single dose cohorts of orally administered 500, 2500 and 7500 ova. Each cohort had 12 patients, with nine patients receiving TSO and three receiving placebo.


CNDO-109

CNDO-109 is a lysate (disrupted CTV-1 cells, cell membrane fragments, cell proteins and other cellular components) that activates donor NK cells. CTV-1 is a leukemic cell line recently re-classified as a T-cell acute lymphocytic leukemia (ALL). The Company has worldwide rights to develop and commercialize CNDO-109 activated NK cells for the treatment of cancer fro! m UCLB. In February 2012, the Company submitted an IND for the CNDO-109 activated NK cell product in the United States. The treatment of patients with CNDO-109 activated NK cells involves several steps. The activated NK cells are infused into the patient after resting NK cells are incubated with CNDO-109 for at least eight hours. Preparation of CNDO-109 activated NK cells takes about 24 hours from start to finish.


The Company competes with Centocor Ortho Biotech Inc.’s Remicade , UCB S.A.’s Cimzia, Abbott Laboratories’ Humira, Biogen Idec’s Avonex, Bayer Healthcare Pharmaceuticals’ Betaseron, Teva Pharmaceuticals Industries, Ltd.’s Copaxone and Novartis AG’s Gilenya.

Advisors’ Opinion:

  • [By Roberto Pedone]

    One under-$10 biopharmaceutical player that’s quickly moving within range of triggering a major breakout trade is Coronado Biosciences (CNDO), which is focused on novel immunotherapy biologic agents for autoimmune diseases and cancer. This stock has been hit hard by the bears in 2013, with shares off by 43%.


    If you take a look at the chart for Coronado Biosciences, you’ll notice that this stock has been uptrending strong since it double bottomed in November, with shares moving higher from its low of $1.25 to its intraday high of $2.58 a share. During that uptrend, shares of CNDO have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CNDO within range of triggering a major breakout trade.

    Traders should now look for long-biased trades in CNDO if it manages to break out above some key overhead resistance at $2.70 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.97 million shares. If that breakout hits soon, then CNDO will set up to re-fill some of its previous gap down zone from October that started near $7 a share. Some possible upside targets if CNDO gets into that gap with volume are $4 to $5 a share.


    Traders can look to buy CNDO off any weakness to anticipate that breakout and simply use a stop that sits right around some key near-term support at $2 a share. One can also buy CNDO off strength once it takes out $2.70 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Ben Fox Rubin]

    Biopharmaceutical firm Coronado Biosciences Inc.(CNDO) said a recent pilot study found that the first five patients using its potential autism treatment showed statistically significant separation from placebo, in favor of the drug. The treatment was also well-tolerated. The study is still ongoing. Shares jumped 26% to $2.25 premarket.

  • [By James E. Brumley]

    The last few weeks haven’t been particularly encouraging for Crohn’s disease sufferers. In August, GlaxoSmithKline (NYSE: GSK) and ChemoCentryx (NASDAQ:CCXI) reported that a jointly-developed Crohn’s drug, vercirnon, had failed to meet its late-stage trial endpoints. Though the in-development drug isn’t dead in the water (GSK and CCXI could rework the drug, the testing regimen, or use it for other indications), it doesn’t look good. Then this month – just a few days ago – Coronado Biosciences Inc. (NASDAQ:CNDO) reported that its Phase 3 trials of Crohn’s disease drug TSO had also failed to meet its primary endpoints as well. Like vercirnon, CNDO isn’t completely out of luck here with the treatment, but forging ahead with further development of the treatment is grasping at straws. Crohn’s sufferers don’t need to give up home just yet, however – TNI Biotech Inc. (OTCMKTS:TNIB) appears to have a Crohn’s treatment that works, and should be able to sidestep the problems that pl agued ChemoCentryx, GlaxoSmithKline, and Coronado Biosciences.

10 Best Up And Coming Stocks To Watch Right Now: TripAdvisor Inc (TRIP)


TripAdvisor, Inc. (TripAdvisor), incorporated on July 20, 2011, is an online travel research company, enabling users to plan and have a trip. TripAdvisor features reviews and advice on hotels, resorts, flights, vacation rentals, vacation packages and travel guides. TripAdvisor’s travel research platform features reviews and opinions from its community of travelers about destinations, accommodations (hotels, bed and breakfasts, specialty lodging and vacation rentals), restaurants and activities worldwide, through its TripAdvisor brand. TripAdvisor Websites include tripadvisor.com in the United States and versions of the Website in 30 countries, including in China under the brand daodao.com. TripAdvisor Websites also include links to the Websites of its travel advertisers allowing travelers to directly book their travel arrangements. In addition to the TripAdvisor brand, TripAdvisor, Inc. manages and operates Websites under 18 other travel media brands, providing travel pl anning resources across the travel sector. On December 20, 2011, Expedia, Inc. (Expedia) completed the spin-off of TripAdvisor, Inc. (TripAdvisor) to Expedia stockholders. TripAdvisor consists of the domestic and international operations previously associated with Expedia’s TripAdvisor Media Group. In October 2012, it acquired Wanderfly. In March 2013, it acquired Tiny Post (tinypost.co). In April 2013, the Company acquired Jetsetter.com and Gilt Travel Inc. In May 2013, TripAdvisor Inc acquired key technology and talent from CruiseWise Inc. In May 2013, TripAdvisor Inc acquired Guia de Apartamentos Niumba SL. In June 2013, the Company announced that it has acquired GateGuru.


TripAdvisor provides access worldwide to online travel agencies, including Expedia, Orbitz, Travelocity, hotels.com, Priceline and Booking.com. TripAdvisor Media Group offers travel suppliers graphical advertising and cost-per-click marketing platforms. TripAdvisor operates sites in 30 co untries and in 21 languages, including sites in the United S! tates (http://www.tripadvisor.com), the United Kingdom (http://www.tripadvisor.co.uk), France (http://www.tripadvisor.fr), Ireland (http://www.tripadvisor.ie), Germany (http://www.tripadvisor.de), Italy (http://www.tripadvisor.it), Spain (http://www.tripadvisor.es), India (http://www.tripadvisor.in), Japan (http://www.tripadvisor.jp), Portugal and Brazil (http://www.tripadvisor.com.br), Sweden (http://www.tripadvisor.se), The Netherlands (http://www.tripadvisor.nl), Canada (http://www.tripadvisor.ca), Denmark (http://www.tripadvisor.dk), Turkey (http://www.tripadvisor.com.tr), Mexico (http://www.tripadvisor.com.mx), Norway (http://no.tripadvisor.com), Poland (http://pl.tripadvisor.com), Australia (http://www.tripadvisor.com.au), Singapore (http://www.tripadvisor.com.sg), Thailand (http://th.tripadvisor.com), Russia (http://www.tripadvisor.ru), Greece (http://www.tripadvisor.com.gr), Indonesia(http://www.tripadvisor.co.id), Argentina (www.tripadvisor.co.ar), Taiwan (www.tripa dvisor.tw),Malaysia(http://www.tripadvisor.com.my), and Egypt (http://www.tripadvisor.com.eg). TripAdvisor also operates in China under the brand daodao.com (http://www.daodao.com) and Kuxun.cn (http://www.kuxun.cn).


Advisors’ Opinion:

  • [By Ben Levisohn]

    The anarchists in Chumbawamba might not like the reference, but momentum stocks like Tesla Motors (TSLA), Netflix (NFLX) and TripAdvisor (TRIP), after getting knocked down, have gotten up again.

  • [By Ben Levisohn]

    Trip Advisor (TRIP), meanwhile, jumped 15% to $94.42, its biggest weekly gain since July 2013. Trip Advisor purchased lafourchette this week, while Italy said it was investigating the travel booking site to see if it too appropriate steps to keep fake opinions off the website.

  • [By Ben Levisohn]

    Stocks are displaying their resilience after making back their early-morning losses today, as Pfizer (PFE), Walt Disney (DIS), TripAdvisor (TRIP), Netflix (NFLX) and Johnson Controls (JCI) have gained.

  • [By Louis Navellier]

    TripAdvisor (TRIP), which calls itself “the world’s largest travel website,” reported an excellent quarter last week. TripAdvisor reported total revenue of $281 million, up 32% quarter over quarter and 22% year over year. Net income of $68 million, or $0.47 per diluted share, was up 240% sequentially and 10% over the year-ago period. TRIP missed the analysts’ estimates by about 1% but TripAdvisor raised guidance for the rest of the year — and that has Wall Street excited about the travel stock right now.

10 Best Up And Coming Stocks To Watch Right Now: Courier Corporation(CRRC)


Courier Corporation, together with its subsidiaries, engages in printing, publishing, and selling books. It operates in two segments, Book Manufacturing and Specialty Book Publishing. The Book Manufacturing segment produces hard and softcover books, as well as offers related services involved in managing the process of creating and distributing these products for publishers, religious organizations, and other information providers. The Specialty Book Publishing segment publishes books in approximately 30 specialty categories, including fine and commercial arts, children?s books, crafts, music scores, graphic design, mathematics, physics and other areas of science, puzzles, games, social science, stationery items, and classics of literature for juvenile and adult markets in the United States. This segment also publishes approximately 900 test preparation and study guide titles for teachers and other consumers; and 130 titles comprising books on home decoration, design, and improvement, as well as gardening and landscaping for the home and garden retail book market. This segment sells its products through its specialty catalogs and through the Internet at doverpublications.com, REA.com, and creativehomeowner.com; and maintains DoverDirect.com, which is a business-to-business site for its retailers and distributors. This segment also sells its products through bookstore chains, independent booksellers, mass merchandisers, children?s stores, craft stores, gift shops, college bookstores, teachers? supply stores, and home and garden centers, as well as through a range of distributors in the United States and internationally. The company was founded in 1824 and is headquartered in North Chelmsford, Massachusetts.


Advisors’ Opinion:

  • [By Tim Melvin]

    CPLP reaffirmed its commitment to paying the dividend of 93 cents per share going forward, and at that level the shares yield 8.65%. The F score is 7, so conditions are improving for the company and the stock is actually trading at a more than a 35% discount to its Graham number valuation of $16.

    Courier Corporation (CRRC)

    Courier Corporation (CRRC) publishes and prints books that are distributed through a variety of retail outlets. It publishes books on things like landscaping, gardening and home improvement that are found in many of the leading home and garden stores. Courier also publishes more than 700 test preparation and study guides for teachers and students as well books for religious institutions.

10 Best Up And Coming Stocks To Watch Right Now: CardioNet Inc.(BEAT)


CardioNet, Inc. provides real-time ambulatory outpatient management solutions for monitoring clinical information regarding an individual’s health to cardiologists and electro physiologists in the United States. The company focuses on the diagnosis and monitoring of cardiac arrhythmias through its Mobile Cardiac Outpatient Telemetry (MCOT) system, and event and Holter monitors. Its MCOT system is a real-time arrhythmia monitoring solution that incorporates a patient-worn sensor attached to leads, which captures ECG data and communicates wirelessly with a compact monitor that analyzes incoming information by applying proprietary algorithms and automatically transmits the ECG data to the CardioNet Monitoring Center, where cardiac monitoring specialists analyze the sent data and report results in the manner prescribed by the physician. The company also provides event monitoring services by using event monitors to record and store up to 540 seconds of ECG signal; Holter monito ring services by using Holter monitors to record a continuous ECG signal for one to two days; and pacemaker monitoring services for the periodic monitoring and evaluation of pacemakers implanted on patients. In addition, it engages in the development, manufacture, and marketing of medical devices and related software to medical companies, clinics, and hospitals. CardioNet, Inc. was incorporated in 1994 and is headquartered in Conshohocken, Pennsylvania.


Advisors’ Opinion:

  • [By GuruFocus]

    George Soros (Trades, Portfolio) just reported his first quarter portfolio. He buys Citrix Systems Inc, Baker Hughes Inc, Comcast Corp, Spansion Inc, etc during the 3-months ended 03/31/2014, according to the most recent filings of his investment company, Soros Fund Management LLC. As of 03/31/2014, Soros Fund Management LLC owns 305 stocks with a total value of $10.1 billion. These are the details of the buys and sells.New Purchases: BHI, CODE, CTRP, CLI, AVB, COMM, CNQ, AGO, AUY, ATML, ASH, BXMT, CSTM, AEM, CMA, ARE, CHKP, AUQ, BEAV, CX, ADSK, AALCP, BLK, AIG, BIIB, ADEP, AMRI, ARWR, ATHX, BALT, BCRX, BEAT, CFX, CLFD, CUR, CODE,Added Positions: CTXS, CMCSA, CNP, ALTR, BRCD, CBS, CRM, CHTR, CCJ, CIEN, BIDU, ALLE, ABT, CDNS, ACT,Reduced Positions: AAPL, CCI, AMT, ABBV, AAL, BITA, AL, ANGI, ARIA, CBST, BA, BIRT, EXAR,Sold Out: C, BAC, CRI, AMZN, AGN, CF, BRCM, COTY, BMY, AMCX, CAR, A, ADBE, AFL,For the details of George Soros (Trades, Portfolio)’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=George+SorosThis is the sector weightings of his portfolio:Technology18.9%Energy14%Healthcare8.3%Consumer Defensive8.2%Communication Services8.1%Consumer Cyclical5.4%Industrials5.1%Basic Materials4.9%Financial Services2.5%Real Estate1.9%Utilities0.5%These are the top 5 holdings of George Soros (Trades, Portfolio)1. Teva Pharmaceutical Industries Ltd (TEVA) – 10,310,041 shares, 5.4% of the total portfolio. Shares added by 10.67%2. Herbalife Ltd (HLF) – 4,901,337 shares, 2.8% of the total portfolio. Shares added by 52.9%3. EQT Corp (EQT) – 2,573,814 shares, 2.5% of the total portfolio. Shares added by 3.27%4. Adecoagro SA (AGRO) – 25,915,076 shares, 2.1% of the total portfolio.5. Halliburton Co (HAL) – 3,596,353 shares, 2.1% of the total portfolio. Shares reduced by 20.73%New Purchase: Baker Hughes Inc (BHI)George Soros (Trades, Portfolio) initiated holdings in Baker Hughes Inc. His purchase prices were between $51.82 and $65.2 7, with an estimated

  • [By Lauren Pollock]

    BioTelemetry Inc.’s(BEAT) third-quarter loss narrowed slightly as the wireless medical technology company logged volume growth in its patient services segment, in part due to its contract with UnitedHealth Group Inc.(UNH) Shares jumped 12% to $10.12 premarket as the company reported a surprise adjusted profit.

  • [By Bryan Murphy]

    Look out Intuitive Surgical, Inc. (NASDAQ:ISRG), and step aside BioTelemetry Inc. (NASDAQ:BEAT). There’s a new cardiac name in town, and its name is Stereotaxis Inc. (NASDAQ:STXS). This small company’s stock is soaring today on the heels of encouraging news, though the prompt for the stock’s strength has been brewing for quite some time. This nudge for STXS, however, may well mean it has a lot more potential than ISRG or BEAT do for the foreseeable future.

10 Best Up And Coming Stocks To Watch Right Now: Pioneer Southwest Energy Partners L.P.(PSE)


Pioneer Southwest Energy Partners L.P. engages in the ownership and acquisition of oil and natural gas properties in the United States. As of December 31, 2009, it had non-operated working interests in approximately 1,155 producing wells located in the Spraberry field in the Permian Basin of west Texas. Pioneer Natural Resources GP LLC serves as the general partner of the company. The company was founded in 2007 and is based in Irving, Texas. Pioneer Southwest Energy Partners L.P. is a subsidiary of Pioneer Natural Resources USA, Inc.

Advisors’ Opinion:

  • [By Robert Rapier]

    Pioneer Southwest Energy Partners (NYSE: PSE) closes out the top five MLP performers for the year with a gain of 87 percent. However, units of this Texas-based upstream MLP that owned more than 1,100 wells in the Permian Basin area are no longer available, as the partnership merged with sponsor Pioneer Natural Resources (NYSE: PXD) on Dec. 17.

10 Best Up And Coming Stocks To Watch Right Now: Stone Energy Corporation(SGY)

Stone Energy Corporation, an independent oil and natural gas company, engages in the acquisition, exploration, exploitation, development, and operation of oil and gas properties in the Gulf of Mexico and the Appalachia region. As of December 31, 2010, it had estimated proved oil and natural gas reserves of approximately 473.9 billion cubic feet of gas equivalent. The company was founded in 1993 and is headquartered in Lafayette, Louisiana with additional offices in New Orleans, Louisiana; Houston, Texas; and Morgantown, West Virginia.


Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Leading and Lagging Sectors
    In trading on Tuesday, energy shares were relative leaders, up on the day by about 1.41 percent. Meanwhile, top gainers in the sector included Stone Energy (NYSE: SGY), up 9 percent, and Westmoreland Coal Co (NYSE: WLB), up 7.8 percent. Industrials services shares gained by just 0.02 percent in Tuesday’s trading.

  • [By Jake L’Ecuyer]

    Leading and Lagging Sectors
    In trading on Tuesday, energy shares were relative leaders, up on the day by about 1.41 percent. Meanwhile, top gainers in the sector included Stone Energy (NYSE: SGY), up 9 percent, and Westmoreland Coal Co (NYSE: WLB), up 7.8 percent. Industrials services shares gained by just 0.02 percent in Tuesday’s trading.

  • [By John Udovich]

    Yesterday, small cap Energy XXI (Bermuda) Limited (NASDAQ: EXXI) announced a deal to acquire EPL Oil & Gas Inc (NYSE: EPL) to create the largest publicly held independent oil producer on the Gulf of Mexico shelf, meaning it might be a good idea to look at other small cap Gulf oil stocks like W&T Offshore, Inc (NYSE: WTI), Stone Energy Corporation (NYSE: SGY) and Contango Oil & Gas Company (NYSEMKT: MCF). Energy XXI’s CEO John Schiller has talked about the details of the acquisition with Jim Cramer on CNBC’s “Mad Money” and he noted that  EPL Oil & Gas offers areas of expertise that EXXI currently lacks. However, investors who missed out on yesterday’s 29% surge for EPL Oil & Gas may want to check out these other small cap Gulf Oil stocks:

10 Best Up And Coming Stocks To Watch Right Now: Vocera Communications Inc (VCRA)


Vocera Communications, Inc. (Vocera), incorporated on February 16, 2000, is a provider of mobile communication solutions. The Company’s solutions consist of its Voice Communication, Messaging and Care Transition solutions. Its Voice Communication solution, which includes a communication badge and a software platform, enables users to connect with other hospital staff. The Company’s Messaging solution delivers text messages and alerts directly to and from smartphones. Its Care Transition solution is a voice and text-based software application that captures, manages and monitors patient information when responsibility for the patient is transferred or handed-off from one caregiver to another, or when the patient is discharged from the hospital. Users can communicate with others using the Vocera communication badge or through Vocera Connect client applications available for BlackBerry, iPhone and Android smartphones, as well as Cisco wireless Internet protocol (IP) phones and other mobile devices. In January 2014, Vocera Communications Inc announced the acquisition of mVisum.


Communication solution can also be integrated with nurse call and other clinical systems to alert hospital workers to patient needs. The Company’s solutions are deployed in over 800 hospitals and healthcare facilities, including hospital systems, hospitals, and clinics, surgery centers and aged-care facilities. During the year ended December 31, 2011, the Company had shipped over 400,000 communication badges to its customers. The Company outsources the manufacturing of its products. Vocera offers a range of services, including clinical workflow design, wireless assessment, solution configuration, training and project management. It also provides a classroom-based curriculum for systems administrators, information technology professionals and clinical educators. The Company provides around-the-clock technical support to its customers through its support c enters in San Jose, California, and Reading, United Kingdom.!


Voice Communication solution

The Company’s Voice Communication solution consists of a software platform that connects communication devices, including its hands-free, wearable, voice-controlled communication badges, Vocera-branded smartphones and third-party mobile devices that use its software applications to become part of the Vocera system. The system transforms the way mobile workers communicate by enabling them to connect with the right person simply by the name, function or group name of the person they want to reach, often while remaining at the point-of-care. Its system responds to over 100 voice commands.


Vocera’s Voice Communication solution is a software platform that runs on its customers’ Windows-based servers. In addition, it controls the calling and messaging functions of the mobile client devices and maintains profiles for users and groups that enable customization of workflow patterns for each customer. The Compa ny’s communication badge is a wearable device that operates over customers’ wireless fidelity (Wi-Fi) networks. The badge is worn clipped to a shirt or on a lanyard. It can be used to conduct hands-free communication. It enables two-way voice conversations without the need to remember a phone number or use a handset. Its badge also incorporates automatic diagnostic mechanisms that feed data on wireless network performance back to the software platform for reporting and diagnosis of problems. In October 2011, it introduced the Vocera B3000 badge. In 2012, the Company added Cisco wireless IP phones to the list of mobile devices it supports.


Messaging solution

The Company’s Messaging solution delivers text messages, alerts and other information, directly to and from smartphones. Its solution consists of a software platform and client applications that run on BlackBerry, iPhone or Android devices. Its Messaging solution includes a range of client applications, including Alert, Chat and Commander.

Care! Transition Solution

The Company’s platform, which includes modules for patient transfers, shift changes, physician sign-outs and patient and family information exchanges, allows hospitals to standardize and monitor patient hand-offs. Its Care Transition solution can be deployed through either a hosted software-as-a-service model or as a server-on-site model and has been deployed by over 120 hospitals.


The Company competes with Cisco Systems, Ascom and Polycom.

Advisors’ Opinion:

  • [By gurujx]

    Vocera Communications Inc (VCRA) Reached the 3-year Low of $12.33

    The prices of Vocera Communications Inc (VCRA) shares have declined to close to the 3-year low of $12.33, which is 64.4% off the 3-year high of $32.97.

  • [By Victor Selva]

    On Dec.24, Mario Gabelli, the Chairman and Chief Executive Officer of GAMCO Investors, Inc. added Communications Systems Inc. (JCS) at an average price of $11.05 and currently holds 330,172 shares of the stock. It was the 5th time he added the stock during this year, which makes me feel that he is betting in favor of a positive future for the consumption of network capacity.
    Recommendations of the Board
    Communications Systems is engaged in the manufacture and sale of modular connecting and wiring devices for voice and data communications, digital subscriber line filters, and structured wiring systems, and through its Transition Networks business unit in the manufacture of media and rate conversion products for telecommunications networks.
    Few months ago the firm announced a series of actions to increase revenues and improve profitability. The first change was to operate as a holding company, monitoring and supporting all the business units: Suttle, Transition Ne tworks (TN) unit and JDL Technologies. With this “new format”, each unit will operate with a high degree of autonomy. This will result in the reduction of labor costs, the emphasizing of accountability in the units as well as better recognition of performance. “While difficult decisions for the Board, we believe the changes we have taken to restructure our parent company as a holding company and to focus on individual business unit performance is in the best interest of our shareholders and will increase shareholder value” said Curtis A. Sampson, the Company’s Board Chair and Interim CEO. Furthermore, strategic investments in the TN unit such as marketing, sales and product development will boost revenues in the future.
    Severe Warning Signs
    Not all are good news, we found three severe warning signs issued by GuruFocus: Piotroski F-Score of 2 is low, which usually implies poor business operation; revenue has been in decline over the past 3 years and operating margi n has been in 5-year

10 Best Up And Coming Stocks To Watch Right Now: Life Technologies Corporation(LIFE)


Life Technologies Corporation operates as a global life sciences company. The company?s Molecular Biology Systems division offers molecular biology-based technologies, including basic and real-time PCR, RNA interference, DNA synthesis, sample preparation, transfection, cloning and protein expression profiling, protein analysis, and thermo-cycler instrumentation technologies. Its Cell Systems division provides cell culture media and sera, stem cells and related tools, cellular imaging products, antibodies, drug discovery services, and cell therapy related products used in the study of cell function. The company?s Genetic Systems division offers capillary electrophoresis systems and reagents, and next generation sequencing systems and reagents comprising SOLiD and Ion Torrent systems, as well as reagent kits developed specifically for applied markets, such as forensics and food safety, pharmaceutical quality monitoring, and animal health markets. Life Technologies Corporat i on also provides repair and maintenance services; and custom services, such as cell line development, custom media modification, and primers and custom assays development services. Its products offer research tools for genomics studies, proteomics studies, gene splicing, cellular analysis, and other research applications required by laboratories associated with universities, medical research centers, and government and other research institutions, as well as biotechnology, pharmaceutical, and chemical companies; and serves clinical labs, medical institutions, medical researchers, and various industries through sales and service professionals, e-commerce capabilities, and onsite supply center solutions. The company was founded in 1987 and is headquartered in Carlsbad, California.

Advisors’ Opinion:

  • [By Rich Duprey]

    Competition has been fierce among gene sequencing firms, but for the right players, business has been good. Life Technologies (NASDAQ: LIFE  ) is being wooed by a number of suitors, including a bevy of private equity firms along with Thermo Fisher who all want access to Life’s leading genetic sequencing equipment. Bids north of $11 billion are expected, which is said to be the biggest buyout in the space since Thermo Electron bought Fisher Scientific for almost $13 billion in 2006 to create Thermo Fisher.

  • [By David Williamson]

    Shares of Life Technologies (NASDAQ: LIFE  ) jumped in January, when the company announced it was looking for a potential buyer, and it may now be close to a decision, with solid offers having come in both from Blackstone Group (NYSE: BX  ) and Thermo Fisher Scientific (NYSE: TMO  ) . What will this biotech decide, and how will it affect investors? In this video, Motley Fool health-care analyst David Williamson gives us a breakdown of the offers on the table, and how investors could be affected depending on the outcome.

  • [By Rich Smith]

    The Wall Street Journal calls Carlsbad, Calif.-based Life Technologies (NASDAQ: LIFE  ) an $11 billion “company you never heard of.” As the Journal reports, a buyout group including private-equity powerhouses Blackstone (NYSE: BX  ) , Carlyle Group (NASDAQ: CG  ) , and KKR (NYSE: KKR  ) is putting together an $11 billion bid to acquire the lab research equipment manufacturer. But as it turns out, Life is doing a bit of acquiring itself.